Received Apr 10, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 947357 | IM / RA |
Patient complaining of erythema, warmth, swelling and pain at the injection site. No treatment provided as of yet. Patient counseled on seeking medical care if condition worsens.
No.
No.
No.
No.
Not at this time.